SGLT2 inhibitors like empagliflozin and dapagliflozin lower blood sugar but also cause fluid loss, leading to dehydration, dizziness, and lower blood pressure. Learn who’s at risk and how to manage these side effects safely.
SGLT2 inhibitors like empagliflozin and dapagliflozin lower blood sugar but also cause fluid loss, leading to dehydration, dizziness, and lower blood pressure. Learn who’s at risk and how to manage these side effects safely.